Videos
WEBINAR: September 3, 2025
Next-gen vectors:
advancing in vivo and ex vivo gene delivery through intelligent design
BioInsights
Speakers
Nagy Habib MD, ChM, FRCS
CEO, Dawn Therapeutics
John Maher, MD
Chief Science Officer, Leucid Bio
Carlo Scala, PhD
Director of Process Development and Innovation, ViroCell Biologics
Moderator
Abigail Pinchbeck, Editor, BioInsights
PANEL: April 16, 2025
Advancing Gene Therapies for Rare Diseases: Implementing Novel Strategies for Not-For-Profit Innovation
Alliance for Regenerative Medicine, Rome
Moderator
John W. Hadden II, CEO, ViroCell Biologics
Panelists
Hilary Eaton, PhD, Chief Business Officer, Profluent.bio
Sadik Kassim, PhD, Chief Scientific Officer and Chief Technology Officer, Danaher Genomic Medicines
Maryam Mokhtarzadeh, MD, Senior Director, Regulatory Strategy, REGENXBIO
Hilary Schultz, CEO and Founder, Persephoni BioPartners